Insider Buying: Fluidigm Corporation (FLDM) Insider Purchases 4,227 Shares of Stock

Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. acquired 4,227 shares of the firm’s stock in a transaction on Wednesday, October 25th. The shares were bought at an average cost of $5.42 per share, for a total transaction of $22,910.34. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, November 8th, Levin Capital Strategies, L.P. bought 54,900 shares of Fluidigm Corporation stock. The shares were acquired at an average price of $5.26 per share, for a total transaction of $288,774.00.
  • On Monday, October 23rd, Levin Capital Strategies, L.P. bought 22,363 shares of Fluidigm Corporation stock. The shares were acquired at an average price of $5.47 per share, for a total transaction of $122,325.61.
  • On Thursday, October 19th, Levin Capital Strategies, L.P. bought 60,000 shares of Fluidigm Corporation stock. The shares were acquired at an average price of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. bought 144,200 shares of Fluidigm Corporation stock. The shares were acquired at an average price of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. bought 50,000 shares of Fluidigm Corporation stock. The shares were acquired at an average price of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. purchased 95,843 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. purchased 60,000 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $5.25 per share, for a total transaction of $315,000.00.
  • On Thursday, August 17th, Levin Capital Strategies, L.P. purchased 465 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.66 per share, for a total transaction of $1,701.90.
  • On Thursday, August 10th, Levin Capital Strategies, L.P. purchased 4,003,129 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.30 per share, for a total transaction of $13,210,325.70.
  • On Wednesday, August 9th, Levin Capital Strategies, L.P. purchased 1,549 shares of Fluidigm Corporation stock. The stock was purchased at an average price of $3.18 per share, for a total transaction of $4,925.82.

Shares of Fluidigm Corporation (FLDM) opened at $5.24 on Friday. The company has a quick ratio of 1.76, a current ratio of 3.02 and a debt-to-equity ratio of 5.00. Fluidigm Corporation has a fifty-two week low of $2.52 and a fifty-two week high of $8.69.

COPYRIGHT VIOLATION WARNING: “Insider Buying: Fluidigm Corporation (FLDM) Insider Purchases 4,227 Shares of Stock” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.dispatchtribunal.com/2017/11/12/levin-capital-strategies-l-p-buys-4227-shares-of-fluidigm-corporation-fldm-stock.html.

Separately, ValuEngine upgraded shares of Fluidigm Corporation from a “strong sell” rating to a “sell” rating in a report on Monday, October 23rd.

Several institutional investors and hedge funds have recently modified their holdings of the company. Russell Investments Group Ltd. grew its stake in shares of Fluidigm Corporation by 46.8% during the 3rd quarter. Russell Investments Group Ltd. now owns 3,447,491 shares of the medical research company’s stock worth $17,370,000 after acquiring an additional 1,099,072 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Fluidigm Corporation by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 1,181,883 shares of the medical research company’s stock worth $6,725,000 after acquiring an additional 19,669 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Fluidigm Corporation by 2.4% during the 1st quarter. Wellington Management Group LLP now owns 630,277 shares of the medical research company’s stock worth $3,587,000 after acquiring an additional 14,814 shares in the last quarter. State Street Corp grew its stake in shares of Fluidigm Corporation by 6.2% during the 2nd quarter. State Street Corp now owns 499,524 shares of the medical research company’s stock worth $2,017,000 after acquiring an additional 29,110 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Fluidigm Corporation by 5.6% during the 1st quarter. Renaissance Technologies LLC now owns 476,400 shares of the medical research company’s stock worth $2,711,000 after acquiring an additional 25,100 shares in the last quarter. 88.57% of the stock is owned by institutional investors.

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply